Delphine Heenen
Anticancer Fund(BE)
Publications by Year
Research Areas
Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research, Pharmaceutical studies and practices, Sarcoma Diagnosis and Treatment, CAR-T cell therapy research
Most-Cited Works
- → Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents(2020)43 cited
- → Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)(2024)42 cited
- → Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer(2021)37 cited
- → Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children(2020)25 cited
- → Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas(2022)23 cited
- → 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers(2018)22 cited
- → Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer(2017)21 cited
- → Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration(2023)14 cited
- → Prevalence of childhood cancer survivors in Europe: a scoping review(2024)10 cited
- → New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis(2025)6 cited